Skip to Main Content

Paper Details

The safety and immunogenicity of a two-dose schedule of CoronaVac, and the immune persistence of vaccination for six months, in people living with HIV: A multicenter prospective cohort study.
Front Immunol
4
2023
Author NameAffiliation
Li WangHeilongjiang Provincial Hospital
  • 1 - 1

Datasets

Release 1.2